Jan 13, 2026 10:15
KVUE - Kenvue Inc.
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 16.16 0.43 (2.69%) | 0.04 (0.21%) | 0.02 (0.12%) | 0.13 (0.76%) | 0.08 (0.5%) | 0.34 (2.12%) | 0.09 (0.56%) | 0.08 (0.5%) |
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.
Earnings & Ratios
- Basic EPS:
- 0.22
- Diluted EPS:
- 0.22
- Basic P/E:
- 75.4318
- Diluted P/E:
- 75.4318
- RSI(14) 1m:
- 71.88
- VWAP:
- 16.57
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|
Related News
Jan 05, 2026 15:18
Jan 02, 2026 17:30
Jan 02, 2026 14:15
Dec 14, 2025 18:18
Dec 13, 2025 16:50
Dec 12, 2025 18:20
Nov 22, 2025 10:09
Nov 05, 2025 23:27
Nov 05, 2025 18:37